In addition, gene amplifications, point mutations and chromosomal truncations of NF-κB signaling genes are associated with occurrence of lymphoid malignancies and leukemia, underlining the direct oncogenic potential of NF-κB signaling. Here, NFKB1 is linked to leukemia.